Driven by audience questions, industry innovators Aaron Fleishman and Craig Lipset discuss maintaining clinical trial momentum during COVID-19 and beyond during our recent virtual town hall.
Watch now to gain insight into overcoming patient enrollment and engagement challenges while supporting study continuity. Learn how to minimize clinical trial disruption with solutions for all stages of study activity – planning, enrolling, and even restarting.
- Craig H. Lipset, Founder, Clinical Innovation Partners LLC, Former Head of Clinical Innovation, Pfizer
- Aaron Fleishman, Director of Market Development, BBK Worldwide